Literature DB >> 21509876

Correlation of diffusion-weighted imaging data with apoptotic and proliferation indexes in CT26 colorectal tumor homografts in balb/c mouse.

Xiao-Yan Zhang1, Ying-Shi Sun, Lei Tang, Wei-Cheng Xue, Xiao-Peng Zhang.   

Abstract

PURPOSE: To investigate whether the percentage of apparent diffusion coefficient (ADC) changes could be used as an imaging marker related to tumor cell apoptotic and Ki-67 proliferation index of tumors.
MATERIALS AND METHODS: Mice bearing CT26 colorectal carcinoma tumors were scanned before radiotherapy, then divided into radiotherapy (n = 24) and control groups (n = 24). Diffusion-weighted imaging (DWI) and anatomic T2WI were performed on six randomly chosen mice in total from two groups at different timepoints after radiotherapy (4, 8, 12 hours, 1, 2, 3, 5, 7 days). After imaging, six animals were sacrificed at each timepoint and histological analyses were undertaken. ADC maps were calculated on a pixel-by-pixel basis using built-in software (Functool, GE). Regions of interest were manually circumscribed for all high-signal areas on lesions observed during DWI. The percentage of ADC changes were calculated at predefined timepoints and compared with the apoptotic and proliferation index from the histological analyses by using the Pearson correlation test.
RESULTS: A significant positive correlation was found between the percentage of ADC changes of the viable tissue and apoptotic index. A significant negative correlation was found between the percentage of ADC changes of the viable tissue and Ki-67 proliferation index.
CONCLUSION: Our results suggest that the percentage of ADC changes can be used as a measurement of cell apoptotic and proliferation index in colorectal carcinoma.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509876     DOI: 10.1002/jmri.22558

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  16 in total

1.  Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation.

Authors:  Yi-Hsiu Chung; Ching-Fang Yu; Shao-Chieh Chiu; Han Chiu; Shin-Ting Hsu; Ching-Rong Wu; Chung-Lin Yang; Ji-Hong Hong; Tzu-Chen Yen; Fang-Hsin Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-24       Impact factor: 9.236

2.  Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.

Authors:  Daniel Fadaei Fouladi; Manijeh Zarghampour; Pallavi Pandey; Ankur Pandey; Farnaz Najmi Varzaneh; Mounes Aliyari Ghasabeh; Pegah Khoshpouri; Ihab R Kamel
Journal:  Eur Radiol       Date:  2019-06-17       Impact factor: 5.315

3.  Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index.

Authors:  Ji Hyun Lee; Young Cheol Yoon; Sung Wook Seo; Yoon-La Choi; Hyun Su Kim
Journal:  Eur Radiol       Date:  2019-10-18       Impact factor: 5.315

4.  Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.

Authors:  Lorenzo Preda; Giorgio Conte; Luke Bonello; Caterina Giannitto; Laura L Travaini; Sara Raimondi; Paul E Summers; Ansarin Mohssen; Daniela Alterio; Maria Cossu Rocca; Chiara Grana; Francesca Ruju; Massimo Bellomi
Journal:  Eur Radiol       Date:  2016-03-10       Impact factor: 5.315

5.  Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Franco Iafrate; Fabio Ciccarelli; Giorgio Maria Masci; Damiano Grasso; Francesco Marruzzo; Francesca De Felice; Vincenzo Tombolini; Giancarlo D'Ambrosio; Fabio Massimo Magliocca; Enrico Cortesi; Carlo Catalano
Journal:  Eur Radiol       Date:  2022-08-18       Impact factor: 7.034

6.  Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.

Authors:  L Heijmen; C J A Punt; E G W Ter Voert; L F de Geus-Oei; A Heerschap; J Bussink; C G J Sweep; V Zerbi; W J G Oyen; P N Span; O Boerman; H W M van Laarhoven
Journal:  Invest New Drugs       Date:  2013-01-17       Impact factor: 3.850

7.  Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation.

Authors:  Linda Heijmen; Edwin E G W Ter Voert; Iris D Nagtegaal; Paul Span; Johan Bussink; Cornelis J A Punt; Johannes H W de Wilt; Fred C G J Sweep; Arend Heerschap; Hanneke W M van Laarhoven
Journal:  Eur Radiol       Date:  2012-09-23       Impact factor: 5.315

8.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.

Authors:  Arthur Varoquaux; Olivier Rager; Karl-Olof Lovblad; Karen Masterson; Pavel Dulguerov; Osman Ratib; Christoph D Becker; Minerva Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

9.  Applicable apparent diffusion coefficient of an orthotopic mouse model of gastric cancer by improved clinical MRI diffusion weighted imaging.

Authors:  Jia Sun; Xiao-Peng Zhang; Xiao-Ting Li; Lei Tang; Yong Cui; Xiao-Yan Zhang; Ying-Shi Sun
Journal:  Sci Rep       Date:  2014-08-15       Impact factor: 4.379

10.  Monitoring early response to anti-angiogenic therapy: diffusion-weighted magnetic resonance imaging and volume measurements in colon carcinoma xenografts.

Authors:  Moritz Jörg Schneider; Clemens Christian Cyran; Konstantin Nikolaou; Heidrun Hirner; Maximilian F Reiser; Olaf Dietrich
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.